Related references
Note: Only part of the references are listed.Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma
Brandon C. Chapman et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2017)
PKCζ, MMP-2 and MMP-9 expression in lung adenocarcinoma and association with a metastatic phenotype
Xiaoshan Cai et al.
MOLECULAR MEDICINE REPORTS (2017)
Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
Tsai-Tsen Liao et al.
MOLECULAR ONCOLOGY (2017)
Low expression of GATA3 promotes cell proliferation and metastasis in gastric cancer
Shuangqin Wei et al.
CANCER MANAGEMENT AND RESEARCH (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Hepatocellular carcinoma recurrence after treatment with direct -acting antivirals: First, do no harm by withdrawing treatment
Harrys A. Torres et al.
JOURNAL OF HEPATOLOGY (2016)
Slit2-Robo1 signaling promotes the adhesion, invasion and migration of tongue carcinoma cells via upregulating matrix metalloproteinases 2 and 9, and downregulating E-cadherin
Yuan Zhao et al.
MOLECULAR MEDICINE REPORTS (2016)
GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas
Toshiaki Haraguchi et al.
PLOS ONE (2016)
HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance
Yun Guan et al.
ONCOTARGET (2016)
Dysfunction of the Reciprocal Feedback Loop between GATA3-and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis
Wenzhe Si et al.
CANCER CELL (2015)
Essential role of GATA3 in regulation of differentiation and cell proliferation in SK-N-SH neuroblastoma cells
Hongwei Peng et al.
MOLECULAR MEDICINE REPORTS (2015)
Hepatocellular carcinoma: clinical frontiers and perspectives
Jordi Bruix et al.
GUT (2014)
GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation
L. Shan et al.
ONCOGENE (2014)
Reduced Expression of Uroplakin 1A Is Associated with the Poor Prognosis of Gastric Adenocarcinoma Patients
Yan Zheng et al.
PLOS ONE (2014)
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer
Masaaki Takai et al.
JOURNAL OF OVARIAN RESEARCH (2014)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation
Tomonori Hosoya et al.
IMMUNOLOGICAL REVIEWS (2010)
GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
Ingeborg B. Engelsen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis
R Mehra et al.
CANCER RESEARCH (2005)
A decade's studies on metastasis of hepatocellular carcinoma
ZY Tang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Cell adhesion system and human cancer morphogenesis
S Hirohashi et al.
CANCER SCIENCE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Altered expression of β-catenin without genetic mutation in intrahepatic cholangiocarcinoma
K Sugimachi et al.
MODERN PATHOLOGY (2001)
Share Paper
